Ibex Investors LLC lowered its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 3.9% in the first quarter, Holdings Channel reports. The fund owned 25,915 shares of the company’s stock after selling 1,050 shares during the quarter. Ibex Investors LLC’s holdings in Prestige Consumer Healthcare were worth $775,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently made changes to their positions in the company. Geode Capital Management LLC lifted its stake in Prestige Consumer Healthcare by 6.5% in the fourth quarter. Geode Capital Management LLC now owns 566,529 shares of the company’s stock valued at $17,493,000 after acquiring an additional 34,514 shares during the last quarter. First Quadrant L P CA bought a new position in Prestige Consumer Healthcare during the fourth quarter worth about $72,000. First Hawaiian Bank increased its position in Prestige Consumer Healthcare by 218.4% during the fourth quarter. First Hawaiian Bank now owns 1,210 shares of the company’s stock worth $37,000 after acquiring an additional 830 shares during the period. Xact Kapitalforvaltning AB increased its position in Prestige Consumer Healthcare by 24.2% during the fourth quarter. Xact Kapitalforvaltning AB now owns 10,781 shares of the company’s stock worth $333,000 after acquiring an additional 2,100 shares during the period. Finally, State of Tennessee Treasury Department bought a new position in Prestige Consumer Healthcare during the fourth quarter worth about $4,411,000.
Shares of PBH traded down $0.16 during mid-day trading on Wednesday, reaching $30.14. The company had a trading volume of 2,996 shares, compared to its average volume of 426,076. Prestige Consumer Healthcare Inc has a 1-year low of $26.25 and a 1-year high of $41.76. The company has a current ratio of 2.37, a quick ratio of 1.43 and a debt-to-equity ratio of 1.64. The company has a market cap of $1.56 billion, a P/E ratio of 10.78, a PEG ratio of 1.72 and a beta of 0.96.
A number of equities analysts recently commented on PBH shares. Royal Bank of Canada reaffirmed a “buy” rating and set a $97.00 price target on shares of Prestige Consumer Healthcare in a research report on Friday, March 15th. TheStreet lowered shares of Prestige Consumer Healthcare from a “c” rating to a “d+” rating in a report on Friday, May 10th. Desjardins downgraded shares of Prestige Consumer Healthcare to a “hold” rating and set a $88.00 price target on the stock. in a research note on Wednesday, February 13th. Zacks Investment Research upgraded shares of Prestige Consumer Healthcare from a “sell” rating to a “hold” rating in a research note on Wednesday, April 24th. Finally, Raymond James downgraded shares of Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating and set a $28.40 price target on the stock. in a research note on Tuesday, January 15th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $54.07.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
See Also: Exchange-Traded Funds (ETFs)
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.